2020 Annual Meeting | C126 - The Palliative Care Guide in Neurology: Best Practice in Communication, Advance Care Planning, and End-of-life Care of Patients with Brain Tumors and Other Life-limiting Neurologic Disorders

Date Tuesday 04/28/20

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Deborah Forst, MD

Topic(s) Neuro-oncology, Pain

Learning Objectives Participants should be able to understand and address challenges associated with assessing prognosis and cultivating prognostic understanding in patients with serious neurological illness and their families. Participants should be able to discuss end-of-life issues with patients and help them develop advance directives, and participants will learn important skills in managing patients' symptoms to optimize their quality of life.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills

Program Level Introductory

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Medical Student

Teaching Styles Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM	Introduction	Introduction and Welcome Deborah Forst, MD
07:05 AM - 07:30 AM	Speaker	Challenges in Formulating and Communicating About Prognosis in Patients with Neurologic Illnesses Kate T. Brizzi, MD
07:30 AM - 07:35 AM	Q&A	Questions and Answers
07:35 AM - 07:55 AM	Speaker	Advance Care Planning and End-of-life Decision-making Deborah Forst, MD
07:55 AM - 08:00 AM	Q&A	Questions and Answers
08:00 AM - 08:25 AM	Speaker	Symptom Management and End-of-life Care for Patients with Life-limiting Neurologic Disease Tobias Walbert, MD, PhD, FAAN
08:25 AM - 08:30 AM	Q&A	Questions and Answers
08:30 AM - 09:00 AM	Discussion	Panel and Discussion

Faculty Disclosures
Deborah Forst, MD	Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.
Kate T. Brizzi, MD	Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Fern Health. Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon.
Tobias Walbert, MD, PhD, FAAN	Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart.

��ɫ��

��ɫ��